Zynerba nabs new patent in U.S.; shares up 5% premarket

The USPTO has issued Zynerba Pharmaceuticals (NASDAQ: ZYNE ), Patent No. 10,314,792, titled Treatment of Autism Spectrum Disorder with Cannabidiol which includes claims directed to methods of treating autism spectrum disorder by administering a therapeutically effective amo…